期刊
PEPTIDES
卷 31, 期 9, 页码 1649-1653出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2010.06.001
关键词
Porphyromonas gingivalis; Lipopolysaccharide; Antibiotics; Inflammation; Cytokines
资金
- US Army Medical Research and Materiel Command for Dental Disease and Trauma Research
Bacterial lipopolysaccharide (LPS) release during periodontal infection is a significant component of periodontal disease. We hypothesized that some bacterial LPS release results from bacterial exposure to antibiotics. Therefore, we examined the ability of various classes of antibiotics to induce LPS release from Porphyromonas gingivalis as well as the ability of antimicrobial peptides (AMPs) to inhibit purified LPS. All antibiotics tested against P. gingivalis were able to liberate 1.9-12.9 times more LPS as compared to untreated bacteria. Among the three AMPs tested. LL-37 was found to be the most potent inhibitor of cytokine (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6) production and completely neutralized purified P. ginigivalis LPS activity in the chromogenic limulus amebocyte lysate (LAL) and whole blood cytokine stimulation assays. These observations suggest that therapeutic approaches utilizing AMPs as adjuncts to neutralize released LPS should be considered. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据